Retraction Note: Dclk1, a tumor stem cell marker, regulates pro-survival signaling and self-renewal of intestinal tumor cells

Parthasarathy Chandrakesan^{1

2

3}, Jiannan Yao^{4

5}, Dongfeng Qu^{4

6

7}, Randal May^{4

7}, Nathaniel Weygant⁴, Yang Ge^{4

5}, Naushad Ali^{4

7}, Sripathi M Sureban^{4

7}, Modhi Gude^{4

8}, Kenneth Vega^{4

9}, Eddie Bannerman-Menson¹⁰, Lijun Xia¹¹, Michael Bronze⁴, Guangyu An¹², Courtney W Houchen^{13

14

15

16}

Affiliations

¹ Division of Digestive Diseases and Nutrition, Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA. parthasarathy-chandrakesan@ouhsc.edu.
² OU Cancer Institute, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. parthasarathy-chandrakesan@ouhsc.edu.
³ Department of Veterans Affairs Medical Center, Oklahoma City, Endocrine, Diabetes, OK, 4Access, USA. parthasarathy-chandrakesan@ouhsc.edu.
⁴ Division of Digestive Diseases and Nutrition, Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA.
⁵ Beijing Chao-Yang Hospital Department of Oncology, Capital Medical University, Beijing, China.
⁶ OU Cancer Institute, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
⁷ Department of Veterans Affairs Medical Center, Oklahoma City, Endocrine, Diabetes, OK, 4Access, USA.
⁸ Thyroid center, Oklahoma City, OK, USA.
⁹ Department of Medicine, National Jewish Health, Denver, CO, USA.
¹⁰ COARE Biotechnology, Oklahoma City, OK, USA.
¹¹ Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.
¹² Beijing Chao-Yang Hospital Department of Oncology, Capital Medical University, Beijing, China. anguangyu@hotmail.com.
¹³ Division of Digestive Diseases and Nutrition, Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA. Courtney-houchen@ouhsc.edu.
¹⁴ OU Cancer Institute, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. Courtney-houchen@ouhsc.edu.
¹⁵ Department of Veterans Affairs Medical Center, Oklahoma City, Endocrine, Diabetes, OK, 4Access, USA. Courtney-houchen@ouhsc.edu.
¹⁶ COARE Biotechnology, Oklahoma City, OK, USA. Courtney-houchen@ouhsc.edu.

PMID: 40253332
PMCID: PMC12008944
DOI: 10.1186/s12943-025-02329-3

Retraction Note: Dclk1, a tumor stem cell marker, regulates pro-survival signaling and self-renewal of intestinal tumor cells

Parthasarathy Chandrakesan et al. Mol Cancer. 2025.

. 2025 Apr 19;24(1):120.

doi: 10.1186/s12943-025-02329-3.

Authors

Affiliations

¹ Division of Digestive Diseases and Nutrition, Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA. parthasarathy-chandrakesan@ouhsc.edu.
² OU Cancer Institute, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. parthasarathy-chandrakesan@ouhsc.edu.
³ Department of Veterans Affairs Medical Center, Oklahoma City, Endocrine, Diabetes, OK, 4Access, USA. parthasarathy-chandrakesan@ouhsc.edu.
⁴ Division of Digestive Diseases and Nutrition, Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA.
⁵ Beijing Chao-Yang Hospital Department of Oncology, Capital Medical University, Beijing, China.
⁶ OU Cancer Institute, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
⁷ Department of Veterans Affairs Medical Center, Oklahoma City, Endocrine, Diabetes, OK, 4Access, USA.
⁸ Thyroid center, Oklahoma City, OK, USA.
⁹ Department of Medicine, National Jewish Health, Denver, CO, USA.
¹⁰ COARE Biotechnology, Oklahoma City, OK, USA.
¹¹ Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.
¹² Beijing Chao-Yang Hospital Department of Oncology, Capital Medical University, Beijing, China. anguangyu@hotmail.com.
¹³ Division of Digestive Diseases and Nutrition, Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA. Courtney-houchen@ouhsc.edu.
¹⁴ OU Cancer Institute, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. Courtney-houchen@ouhsc.edu.
¹⁵ Department of Veterans Affairs Medical Center, Oklahoma City, Endocrine, Diabetes, OK, 4Access, USA. Courtney-houchen@ouhsc.edu.
¹⁶ COARE Biotechnology, Oklahoma City, OK, USA. Courtney-houchen@ouhsc.edu.

PMID: 40253332
PMCID: PMC12008944
DOI: 10.1186/s12943-025-02329-3

No abstract available

PubMed Disclaimer

Retraction of

Dclk1, a tumor stem cell marker, regulates pro-survival signaling and self-renewal of intestinal tumor cells.
Chandrakesan P, Yao J, Qu D, May R, Weygant N, Ge Y, Ali N, Sureban SM, Gude M, Vega K, Bannerman-Menson E, Xia L, Bronze M, An G, Houchen CW. Chandrakesan P, et al. Mol Cancer. 2017 Feb 1;16(1):30. doi: 10.1186/s12943-017-0594-y. Mol Cancer. 2017. Retraction in: Mol Cancer. 2025 Apr 19;24(1):120. doi: 10.1186/s12943-025-02329-3. PMID: 28148261 Free PMC article. Retracted.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- BioMed Central
- PubMed Central

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Retraction Note: Dclk1, a tumor stem cell marker, regulates pro-survival signaling and self-renewal of intestinal tumor cells

Affiliations

Retraction Note: Dclk1, a tumor stem cell marker, regulates pro-survival signaling and self-renewal of intestinal tumor cells

Authors

Affiliations

Retraction of

Publication types

LinkOut - more resources

Full Text Sources